BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3522739)

  • 41. Evidence for sulfate modification of H-2Dd on N-linked carbohydrate(s): possible involvement in Ly-49A interaction.
    Chang CS; Kane KP
    J Immunol; 1998 May; 160(9):4367-74. PubMed ID: 9574541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The class I-b molecule Qa-1 forms heterodimers with H-2Ld and a novel 50-kD glycoprotein encoded centromeric to I-E beta.
    Wolf PR; Cook RG
    J Exp Med; 1995 Feb; 181(2):657-68. PubMed ID: 7836920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular heterogeneity of D-end products detected by anti-H-2.28 sera. II. B10.D2(M504) (H-2dm1) mutant fails to express one of the two H-2.4-, 28 + Dd region molecules.
    Iványi D; Démant P
    Immunogenetics; 1982; 15(5):467-76. PubMed ID: 6980826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular basis of the dm1 mutation in the major histocompatibility complex of the mouse: a D/L hybrid gene.
    Sun YH; Goodenow RS; Hood L
    J Exp Med; 1985 Nov; 162(5):1588-602. PubMed ID: 2997361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unexpected complexity of the dm1 mutation revealed in the structure of three H-2D/L-related antigens.
    Wilson PH; Nairn R; Nathenson SG; Sears DW
    Immunogenetics; 1982 Mar; 15(3):225-37. PubMed ID: 6175568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Control of synthesis and expression of H-2 heavy chain and beta-2 microglobulin in AKR leukemias.
    Schmidt W; Henseling U; Bevec D; Alonzo AD; Festenstein H
    Immunogenetics; 1985; 22(5):483-94. PubMed ID: 2415450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular studies of murine mutant BALB/c-H-2dm2 define a deletion of several class I genes including the entire H-2Ld gene.
    Rubocki RJ; Hansen TH; Lee DR
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9606-10. PubMed ID: 2879284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell surface expression of an in vitro recombinant class II/class I major histocompatibility complex gene product.
    McCluskey J; Germain RN; Margulies DH
    Cell; 1985 Feb; 40(2):247-57. PubMed ID: 2578320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Availability of endogenous peptides limits expression of an M3a-Ld major histocompatibility complex class I chimera.
    Vyas JM; Rich RR; Howell DD; Shawar SM; Rodgers JR
    J Exp Med; 1994 Jan; 179(1):155-65. PubMed ID: 8270862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clonal variation in cell surface display of an H-2 protein lacking a cytoplasmic tail.
    Zuniga MC; Hood LE
    J Cell Biol; 1986 Jan; 102(1):1-10. PubMed ID: 3941149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA sequence of the mouse H-2Dd transplantation antigen gene.
    Sher BT; Nairn R; Coligan JE; Hood LE
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1175-9. PubMed ID: 3856254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alteration within a discrete region of the H-2Ld alpha 1 helix upon association with human beta 2 microglobulin.
    Smith MJ; Basora T; Kieran JE; Nieto MC
    Immunol Cell Biol; 1993 Apr; 71 ( Pt 2)():145-9. PubMed ID: 8486398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphorylation of the avian retrovirus integration protein and proteolytic processing of its carboxyl terminus.
    Horton R; Mumm SR; Grandgenett DP
    J Virol; 1991 Mar; 65(3):1141-8. PubMed ID: 1847443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Construction, expression and recognition of an H-2 molecule lacking its carboxyl terminus.
    Murre C; Reiss CS; Bernabeu C; Chen LB; Burakoff SJ; Seidman JG
    Nature; 1984 Feb 2-8; 307(5950):432-6. PubMed ID: 6363940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The H-2dm1 mutation and Qa antigens.
    Hogarth PM; Walker ID; Rigby AJ; McKenzie IF
    Immunogenetics; 1983; 18(6):617-24. PubMed ID: 6606620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The cytoplasmic domain of the H-2Ld class I major histocompatibility complex molecule is differentially accessible to immunological and biochemical probes during transport to the cell surface.
    Capps GG; Zúñiga MC
    J Biol Chem; 1993 Oct; 268(28):21263-70. PubMed ID: 8407964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide.
    Balendiran GK; Solheim JC; Young AC; Hansen TH; Nathenson SG; Sacchettini JC
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6880-5. PubMed ID: 9192660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1.
    Hasenkrug KJ; Kesari KV; Nathenson SG
    Mol Immunol; 1992 Dec; 29(12):1493-500. PubMed ID: 1280760
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-sensitivity sequence determination of proteins quantitatively recovered from sodium dodecyl sulfate gels using an improved electrodialysis procedure.
    Bhown AS; Mole JE; Hunter F; Bennett JC
    Anal Biochem; 1980 Mar; 103(1):184-90. PubMed ID: 6990828
    [No Abstract]   [Full Text] [Related]  

  • 60. Identification of a BALB/c H-2Ld gene by DNA-mediated gene transfer.
    Goodenow RS; McMillan M; Orn A; Nicolson M; Davidson N; Frelinger JA; Hood L
    Science; 1982 Feb; 215(4533):677-9. PubMed ID: 7058331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.